Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MapLight Therapeutics, Inc. | 211,190 | reported | 27 Apr 2026 | tx 8+212,480−87,521 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Apr 2026 | SALE | MapLight Therapeutics, Inc. | 8,346 | 28.96 USD | 10b5-1 |
| 27 Apr 2026 | SALE | MapLight Therapeutics, Inc. | 29,255 | 29.63 USD | 10b5-1 |
| 27 Apr 2026 | SALE | MapLight Therapeutics, Inc. | 7,821 | 30.50 USD | 10b5-1 |
| 05 Feb 2026 | GRANT_AWARD | MapLight Therapeutics, Inc. | 6,020 | 0.00 USD | |
| 05 Feb 2026 | GRANT_AWARD | MapLight Therapeutics, Inc. | 24,455 | 0.00 USD | deriv |
| 27 Jan 2026 | TAX_WITHHOLDING | MapLight Therapeutics, Inc. | 42,099 | 17.98 USD | |
| 27 Oct 2025 | GRANT_AWARD | MapLight Therapeutics, Inc. | 35,953 | 0.00 USD | |
| 27 Oct 2025 | GRANT_AWARD | MapLight Therapeutics, Inc. | 146,052 | 0.00 USD | deriv |